Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Accounts Payables: 2018-2025

Historic Accounts Payables for Dr Reddys Laboratories (RDY) over the last 8 years, with Mar 2025 value amounting to $417.0 million.

  • Dr Reddys Laboratories' Accounts Payables rose 12.40% to $417.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $417.0 million, marking a year-over-year increase of 12.40%. This contributed to the annual value of $417.0 million for FY2025, which is 12.40% up from last year.
  • As of FY2025, Dr Reddys Laboratories' Accounts Payables stood at $417.0 million, which was up 12.40% from $371.0 million recorded in FY2024.
  • In the past 5 years, Dr Reddys Laboratories' Accounts Payables registered a high of $417.0 million during FY2025, and its lowest value of $322.0 million during FY2023.
  • For the 3-year period, Dr Reddys Laboratories' Accounts Payables averaged around $370.0 million, with its median value being $371.0 million (2024).
  • As far as peak fluctuations go, Dr Reddys Laboratories' Accounts Payables surged by 47.06% in 2021, and later dropped by 4.45% in 2023.
  • Dr Reddys Laboratories' Accounts Payables (Yearly) stood at $325.0 million in 2021, then climbed by 3.69% to $337.0 million in 2022, then decreased by 4.45% to $322.0 million in 2023, then increased by 15.22% to $371.0 million in 2024, then grew by 12.40% to $417.0 million in 2025.